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Abstract
Aims/hypothesis The aim of this study was to examine the
effect of postprandial time on the associations and
predictive value of non-fasting lipid levels and cardiovas-
cular disease risk in participants with diabetes.
Methods This study was conducted among 1,337 participants
with diabetes from the Dutch and German (Potsdam)
contributions to the European Prospective Investigation into
Cancer and Nutrition. At baseline, total cholesterol, LDL- and
HDL-cholesterol and triacylglycerol concentrations were
measured and the ratio of total cholesterol/HDL-cholesterol
was calculated. Participants were followed for incidence of
cardiovascular disease.
Results Lipid concentrations changed minimally with in-
creasing postprandial time, except for triacylglycerol which
was elevated just after a meal and declined over time (1.86
at 0.1 h to 1.33 at >6 h, p for trend <0.001). During a mean
follow-up of 8 years, 116 cardiovascular events were
documented. After adjustment for potential confounders,
triacylglycerol (HR for third tertile compared with first
tertile (HRt3to1), 1.73 [95% CI 1.04, 2.87]), HDL-
cholesterol (HRt3to1, 0.41 [95% CI 0.23, 0.72]) and total
cholesterol/HDL-cholesterol ratio (HRt3to1, 1.65 [95% CI
0.95, 2.85]) were associated with cardiovascular disease,
independent of postprandial time. Cardiovascular disease
risk prediction using the UK Prospective Diabetes Study
risk engine was not affected by postprandial time.
Conclusions/interpretation Postprandial time did not affect
associations between lipid concentrations and cardiovascu-
lar disease risk in patients with diabetes, nor did it influence
prediction of cardiovascular disease. Therefore, it may not
be necessary to use fasting blood samples to determine lipid
concentrations for cardiovascular disease risk prediction in
patients with diabetes.
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Guidelines recommend measuring fasting lipid profiles for
cardiovascular disease (CVD) risk assessment [1]. The
main reason for measurement of lipid concentrations during
the fasting state is the possible increase in triacylglycerol
levels up to 9 h after a meal. However, three different
studies did not find a significant change in total cholesterol,
HDL- or LDL-cholesterol or triacylglycerol over postpran-
dial time [2–4]. This suggests that non-fasting lipid levels
can be used to assess CVD risk in the general population.
However, this may be different for patients with diabetes.
Cholesterol and triacylglycerol concentrations differ between
patients with diabetes and people with normal glucose
tolerance. Patients with diabetes tend to have higher total
cholesterol and triacylglycerol levels and lower HDL-
cholesterol levels [5]. Furthermore, lipid responses after eating
a meal in patients with diabetes are stronger compared with
people with normal glucose tolerance [5]. So far, the effect of
fasting time on the use of lipid levels for prediction of CVD
risk in patients with diabetes has not been investigated.
Therefore, we examined the effect of time since last meal
or drink on the associations of lipid levels and CVD risk in
patients with diabetes. Furthermore, we assessed the effect
of postprandial time on prediction of CVD risk in patients
with diabetes using the UK Prospective Diabetes Study
(UKPDS) risk engine [6].
Methods
The study population consisted of participants with diabetes
from the Dutch and Potsdam (Germany) contributions to the
European Prospective Investigation into Cancer and Nutrition
(EPIC-NL and EPIC-Potsdam, n=67,627) [7, 8]. Both are
observational cohort studies of the general population.
Participants from EPIC-NL were all confirmed diag-
nosed type 2 diabetes patients (total n=387), verified
through medical records of the general practitioner or
pharmacist [9]. In EPIC-Potsdam 265 patients were
confirmed with type 2 diabetes and 685 patients had an
unspecified diabetes type (total n=950), verified through
repeated self-report in follow-up questionnaires.
In total 1,337 participants with diabetes at baseline were
used for the analyses. Exclusion criteria were history of
CVD (n=239) and missing values on lipid concentrations
(n=169). All participants gave written informed consent
prior to study inclusion. Both cohorts were approved by
local ethical committees.
At baseline, participants filled out a general question-
naire regarding demographic characteristics and presence of
chronic diseases. Body weight, height and blood pressure
were measured. Postprandial time was defined as time since
last meal or drink, which was recorded when the partici-
pants provided a blood sample. Total cholesterol, HDL-
and LDL-cholesterol and triacylglycerol concentrations
were measured with the automatic ADVIA 1650 analyser
(Siemens Medical Solutions, Erlangen, Germany) in EPIC-
Potsdam and an auto-analyser (LX20; Beckman Coulter,
Mijdrecht, the Netherlands) was used for the measurements
of the cholesterol concentration for EPIC-NL participants.
HbA1c concentrations were measured in frozen erythrocytes
using an immunoturbidimetric latex test.
Participants were followed for incidence of CVD using
registries in the Netherlands [9] and follow-up questionnaires
with subsequent verification in Germany. Diagnosis of CVD
was coded according to the International Classification of
Diseases (ICD; ICD-9 [www.icd9data.com/2007/Volume1/
240-279/250-259/250/default.htm], ICD codes 410-414,
430-438; ICD-10 [www.who.int/classifications/icd/en/];
ICD codes I20-I25, I60-I67, I69).
Missing values for any of the confounders (ranging from
0.1% to 3.4%) were imputed using single imputation.
Medians and interquartile ranges of lipid concentrations
were examined across four categories of postprandial time
(0–2, 2–4, 4–6 and >6 h) and plotted. Also categorical and
continuous correlations between postprandial time and lipid
concentrations were assessed.
The HR and 95% CI were calculated for each tertile, with
the lowest tertile as reference. Two different models were
constructed. The first model was corrected for age, sex,
smoking, systolic blood pressure, BMI, alcohol, HbA1c
concentration, duration since diagnosis of diabetes, energy
intake, physical activity, diabetes medication and cohort. The
second model was further adjusted for postprandial time as a
continuous variable. Furthermore, HRs for standard devia-
tion increase in lipid concentration were calculated across
tertiles of postprandial time. Models were not adjusted for
statin use because only two patients were using statins.
To investigate the difference in CVD risk prediction over
fasting time, patients were divided into two groups,
according to their postprandial time. A cut-off time between
the two groups of 3 h was used because most patients had a
postprandial time up to 3 h and previous studies have
shown that lipid concentrations after eating a normal meal
might be elevated for 3–4h[ 3, 4].
The UKPDS risk engine was used to calculate 5 year
CVD risk [6]. Discrimination was examined using the
c statistic. Calibration was examined using the Hosmer–
Lemeshow χ
2 test.
Results
Baseline characteristics across tertiles of total cholesterol/
HDL-cholesterol ratio have been examined. Higher total
74 Diabetologia (2011) 54:73–77cholesterol/HDL-cholesterol ratio was associated with a
low education level (first tertile, 34%; third tertile, 41%),
higher mean BMI (kg/m
2) (first, 28.0; third, 30.2), mean
systolic blood pressure (mmHg; first, 139; third, 143) and
percentage HbA1c (first, 7.74; third, 8.50). In total, 73.9%
of the participants were receiving either oral diabetes
medication or insulin.
Only triacylglycerol concentrations declined over post-
prandial time, from 1.86 mmol/l at 0.1 h to 1.33 mmol/l at
>6 h (p value for trend <0.001). While total cholesterol was
4.84 mmol/l at 0.1 h after a meal and 4.51 mmol/l after
>6 h, HDL-cholesterol changed from 1.02 to 1.01 mmol/l
and LDL-cholesterol from 2.83 to 2.79 mmol/l (Fig. 1).
Correlations between time since last meal or drink and
lipid concentrations were only significant for triacylglycer-
ols (p<0.001 for both continuous and categorical correla-
tions). Continuous correlations between total cholesterol
and postprandial time were significant (p=0.04), while
categorical correlations were not (p=0.23)
During a mean follow-up of 8 years, 116 incident cases
of CVD were documented, of which 78 were coronary heart
disease events. Increased triacylglycerol concentrations
were associated with increased risk of CVD, while an
inverse association was observed between levels of HDL-
cholesterol and CVD risk (Table 1). Ratio of total
cholesterol/HDL-cholesterol was associated with an in-
creased CVD risk. Further adjusting for postprandial time
had no effect on the associations (model 2).
CVD HR for a standard deviation increase in lipid
concentrations did not differ across tertiles of postprandial
time (data not shown). The p value for trend was >0.08 for
all lipid concentrations.
Prediction of 5 year CVD risk calculated using UKPDS
risk engine did not differ significantly between patients
who had their lipid levels measured after a postprandial
time of >3 h (n=913) and ≤3h( n=424). A discrimination
of 0.71 (95% CI 0.57, 0.85) for >3 h was only slightly
better than 0.67 (95% CI 0.59, 0.75) for ≤3 h. Calibration
of the model was poor for both fasting-time durations
(p value <0.01 for both time durations).
Discussion
In this cohort of 1,337 patients with diabetes, lipid
concentrations did not change over postprandial time,
except for triacylglycerols. Non-fasting lipid concentrations
were associated with CVD risk independent of postprandial
time. The associations between standard deviation of
increase in lipid concentrations and CVD risk did not differ
over postprandial time, which further strengthens the
hypothesis that associations between lipid concentrations
and CVD risk are not affected by postprandial time.
The strengths of this study are its relatively large sample
size, validation of diabetes cases and geographical distri-
bution of patients (from Germany and the Netherlands), but
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Fig. 1 Median concentrations
over postprandial time for con-
centrations of: (a) total choles-
terol, p=0.003; (b)
triacylglycerol, p=0.001; (c)
HDL-cholesterol, p=0.23; and
(d) LDL-cholesterol, p=0.88.
Error bars represent the inter-
quartile range
Diabetologia (2011) 54:73–77 75some limitations need to be addressed. First, the results may
have been influenced by the limited number of patients
with a postprandial time >8 h, which is the time limit for
complete fasting. However, lipid concentrations did not
change over postprandial time, therefore including more
patients in complete fasting state would not have changed
the results. Second, some differences in measurements
between the cohorts may have occurred. However, the
analyses were adjusted for the cohorts, and therefore it is
unlikely that it affected the results.
Our findings among diabetes patients are in line with
observations in the general population [2–4], although no
association between CVD risk and LDL-cholesterol was
found, as has been observed in other studies. Associations
between triacylglycerols and HDL-cholesterol and CVD
were stronger in our study compared with an earlier study
by Langsted et al. [3]. These differences might be explained
by differences in study population—our study focuses on
diabetes patients whereas other studies focused on the
general population.
Several studies have suggested that non-fasting lipids
might predict CVD risk similarly to or even better than
fasting lipids [2, 10], which is now confirmed by our study.
Therefore it may be unnecessary to measure fasting blood
samples. Fasting requirements make blood sampling more
burdensome for patients. It has been suggested that lipid
levels might increase after a meal. Our study suggests that
lipid levels do not change much in response to eating a
normal meal, except for triacylglycerols. Moreover, post-
prandial time did not affect the ability to predict CVD risk
in diabetes patients. This might be explained by the small
contribution of lipids in CVD risk prediction models and
therefore a slight increase in lipid concentrations after a
meal may not substantially alter the risk [6].
In conclusion, postprandial time did not influence the
association of lipid concentrations with CVD in patients
with diabetes, nor did it affect the prediction of CVD risk.
Therefore it may be unnecessary to use fasting blood
samples to determine lipid concentrations for CVD risk
prediction in patients with diabetes.
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Variable Cases/n Model 1 Model 2
HR (95% CI) HR (95% CI)
Total cholesterol
Tertile 1 (1.71–4.34) 31/449 1.00 1.00
Tertile 2 (4.35–5.21) 40/442 1.15 (0.71, 1.85) 1.16 (0.72, 1.87)
Tertile 3 (5.22–10.56) 45/446 1.05 (0.64, 1.73) 1.05 (0.64, 1.73)
p value for trend 0.88 0.88
Triacylglycerols
Tertile 1 (0.22–1.36) 25/444 1.00 1.00
Tertile 2 (1.37–2.24) 33/446 1.09 (0.64, 1.87) 1.11 (0.65, 1.90)
Tertile 3 (2.25–11.91) 58/447 1.73 (1.04, 2.87) 1.79 (1.07, 2.98)
p value for trend 0.01 0.01
HDL-cholesterol
Tertile 1 (0.40–0.91) 53/445 1.00 1.00
Tertile 2 (0.92–1.14) 44/438 0.96 (0.63, 1.45) 0.95 (0.62, 1.45)
Tertile 3 (1.14–2.56) 19/454 0.41 (0.23, 0.72) 0.41 (0.23, 0.72)
p value for trend 0.002 0.002
LDL-cholesterol
Tertile 1 (0.54–2.48) 37/459 1.00 1.00
Tertile 2 (2.49–3.18) 34/437 0.79 (0.49, 1.28) 0.79 (0.49, 1.28)
Tertile 3 (3.19–6.62) 45/441 0.89 (0.55, 1.42) 0.87 (0.55, 1.40)
p value for trend 0.65 0.61
Ratio total cholesterol/HDL-cholesterol
Tertile 1 (1.73–4.15) 21/445 1.00 1.00
Tertile 2 (4.16–5.27) 42/446 1.76 (1.03, 3.02) 1.76 (1.03, 3.02)
Tertile 3 (5.28–13.82) 53/446 1.65 (0.95, 2.85) 1.65 (0.95, 2.86)
p value for trend 0.14 0.14
Table 1 HRs and 95% CIs for
CVD by tertile of lipid concen-
tration in 1,337 patients with
diabetes mellitus
Model 1 adjusted for age, sex,
cohort, smoking, systolic blood
pressure, BMI, alcohol, HbA1c
level, duration since diagnosis
of diabetes, energy intake,
diabetes medication and
physical activity
Model 2 adjusted for age, sex,
cohort, smoking, systolic blood
pressure, BMI, alcohol, HbA1c
level, duration since diagnosis
of diabetes, energy intake,
diabetes medication, physical
activity and postprandial time
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